文献速递妇科

提高妇科肿瘤微创手术患者当日出院率——加速康复外科质量改进项目

Improving the Rate of Same-Day Discharge in Gynecologic Oncology Patients Undergoing Minimally Invasive Surgery-An Enhanced Recovery After Surgery Quality Improvement Initiative.
PubMed 文献 · J Minim Invasive Gynecol · 2024-02-01

该质量改进项目采用前后对照设计(每组50例),在妇科肿瘤微创手术患者中实施四项干预(默认当日出院计划、术前和术后医嘱集、患者教育材料),将当日出院率从14%(7/50)提升至82%(41/50)(OR 28,P<.001,95%CI 9.54-82.11),且未对术后7天和30天急诊就诊率造成负面影响。

要点

  • 干预后当日出院率从14%(7/50)升至82%(41/50),OR 28(P<.001,95%CI 9.54-82.11)。
  • 术后7天急诊就诊率干预前8% vs 干预后4%(OR 0.48,P=.678,95%CI 0.09-2.74),无显著差异。
  • 术后30天急诊就诊率干预前12% vs 干预后10%(OR 0.8148,P=1.001,95%CI 0.2317-2.86),无显著差异。

核心结论

  • 该加速康复外科质量改进项目使妇科肿瘤微创手术患者当日出院率大幅提高,且未对平衡指标产生负面影响。
  • 作者认为,简单明确的质量改进干预措施在患者群体相似的跨中心推广是可行的,这提示妇科肿瘤加速康复外科当日出院项目对具有相似特征的其他中心可能是现实目标。

研究设计与样本

  • 采用前后对照设计,每组50例患者。
  • 本中心(加拿大阿尔伯塔省卡尔加里)基线审计发现妇科肿瘤患者当日出院率为14%。
  • 基于质量改进诊断识别出的当日出院失败根本原因,设计了四项干预措施。
  • 测量指标包括当日出院率、患者人口学特征和手术结局,并定义和追踪了过程指标与平衡指标。

主要发现

  • 实施干预后,当日出院率从14%(7/50)升至82%(41/50)(OR 28,P<.001,95%CI 9.54-82.11)。
  • 术后7天内急诊就诊率干预前为8%,干预后为4%(OR 0.48,P=.678,95%CI 0.09-2.74)。
  • 术后30天内急诊就诊率干预前为12%,干预后为10%(OR 0.8148,P=1.001,95%CI 0.2317-2.86)。

关键数值与推荐

  • 四项干预措施包括:将当日出院作为默认出院计划并包括「日间手术」手术预约;制定并实施加速康复外科当日出院术前医嘱集;制定并实施加速康复外科当日出院术后医嘱集;提供当日出院专用的患者教育文件。
  • 项目目标之一是将在符合条件的妇科肿瘤患者中的当日出院率提高至70%。

临床怎么用

  • 作者认为,在患者群体相似的各中心之间推广简单明确的质量改进干预措施是可行的。
  • 作者认为,妇科肿瘤加速康复外科当日出院项目对具有相似特征的其他中心可能是现实目标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The objectives of our quality improvement (QI) initiative were (1) to increase the rate of same-day discharge (SDD) in eligible gynecologic oncology (GO) patients to 70% and (2) to evaluate the ease with which QI methods demonstrated in one study could be applied at another center. DESIGN: A pre-/postintervention design was used (50 patients/group). SETTING: SDD in patients undergoing minimally invasive GO surgery is a recent trend aligned with Enhanced Recovery After Surgery (ERAS) principles. SDD in GO is safe and feasible based on several recent studies, including a QI initiative in Edmonton, Alberta, which resulted in SDD rates >70%. PATIENTS: A baseline audit of GO patients at our center (Calgary, Alberta) found the SDD rate to be 14%. Given that Edmonton and our center are within the same province, they have similar patient populations and available resources-suggesting that interventions from the Edmonton QI initiative may be translatable. INTERVENTIONS: Four interventions were designed to address root causes for failed SDD identified after QI diagnostics: (1) SDD as the default discharge plan, including a "Day Surgery" surgical booking; (2 and 3) development and implementation of ERAS SDD preoperative and postoperative order sets; and (4) patient education SDD-specific documents. MEASUREMENTS AND MAIN RESULTS: Rate of SDD was measured together with patient demographics and surgical outcomes. Process and balancing measures were defined and tracked. SDD in GO increased from 14% (7 of 50) to 82% (41 of 50) after the implementation of the above-mentioned interventions (odds ratio [OR], 28; p <.001; 95% confidence interval [CI], 9.54-82.11). Improved SDD was achieved without negatively affecting postoperative rates of emergency department visits: 8% pre- and 4% postintervention within 7 days (OR, 0.48; p = .678; 95% CI, 0.09-2.74) and 12% pre- and 10% postintervention within 30 days (OR, 0.8148; p = 1.001; 95% CI, 0.2317-2.86). CONCLUSION: This ERAS QI initiative resulted in a substantial increase in SDD in GO, without a negative impact on balancing measures. We demonstrate that the "spread" of simple, clearly defined QI interventions across centers (where the patient population is similar) is feasible. This suggests that an ERAS SDD program for GO could be a realistic goal for other centers with similar characteristics.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Mateshaytis J, Trudeau P, Bisch S, et al. Improving the Rate of Same-Day Discharge in Gynecologic Oncology Patients Undergoing Minimally Invasive Surgery-An Enhanced Recovery After Surgery Quality Improvement Initiative. J Minim Invasive Gynecol. 2024. PMID: 38301844. doi:10.1016/j.jmig.2024.01.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。